Form 4 Filing for BIO KEY INTERNATIONAL INC

This filing details a transaction by James David Sullivan, Chief Legal Officer and SVP Strategy & Compliance of BIO KEY INTERNATIONAL INC. On June 30, 2026, Mr. Sullivan acquired 250 shares of common stock under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan. This acquisition, exempt under Rule 16b-3(d) and Rule 16b-3(c), was made at a price of $3.83 per share. Following this transaction, Mr. Sullivan holds 9986 shares. All share amounts have been adjusted to reflect a 1-for-10 reverse stock split effective April 30, 2026.